ETHYL 5-HYDROXYPYRAZOLO[1,5-A]PYRIMIDINE-2-CARBOXYLATE, 97.0%, 1g

p-Xylene, min. 99%, for synthesis, 100 ml, glass packaging

5-Bromo-2-(trifluoromethyl)isonicotinonitrile, 97%, 250mg

N-(3-methoxyphenyl)-1,3,5-triazine-2,4-diamine, 1g

Methyl 2-chloro-6-fluoroquinoline-4-carboxylate, 98%, 100mg

3-Bromo-6-chloro-2-fluorobenzoic acid, 97%, 25g

2-(4-((Benzyloxy)carbonyl)-1,4-diazepan-1-yl)acetic acid hydrochloride, 250mg

1,1,2,3-Tetramethyl-1H-benzo[e]indolium Hexafluorophosphate>97.0%(HPLC)(N)25g

(R)-Ethyl 4-chloro-3-hydroxybutanoate, 95.0%, 100g

5,5-Dimethylhydantoin>98.0%(T)25g

tert-Butyl 3-Oxocyclobutylcarbamate, 97.0%, 5g

ETHYL 2-(PYRIDIN-4-YL)PYRIMIDINE-5-CARBOXYLATE, 95%, 5g

2-Chloro-4-methyl-6-nitroaniline, 95.0%, 5g